相关实验视频
Updated: Jun 18, 2025
07:43
Mouse Models Of Helicobacter Infection And Gastric Pathologies
Published on: October 18, 2018
19.9K
海利科巴克特皮洛里和胆囊病理:是否存在因果关系?
L Gulbani1, L Svanadze2, I Jikia3
11Ivane Javakhishvili Tbilisi State University (TSU); 4Caucasus International University, Tbilisi, Georgia.
Georgian medical news
|August 1, 2024
概括
杆菌感染与胆囊疾病 (如胆囊炎或多) 并没有直接联系. 发现高化学因子CXCL2和CXCL5,但与H. pylori存在无关.
科学领域:
- 胃肠病学 胃肠病学
- 病理学 病理学 病理学
- 微生物学 微生物学
背景情况:
- 胆囊杆菌 (H. pylori) 感染与胆囊疾病 (包括胆囊炎和胆囊聚体) 之间的关联还不清楚.
- 研究H. pylori在胆囊病理中的作用及其对化学因表达的影响对于了解疾病机制至关重要.
研究的目的:
- 为了确定胆囊组织中H. pylori的患病率.
- 在患有胆囊疾病的患者中评估化学因子CXCL2和CXCL5的表达.
- 探索H. pylori感染,化学因表达和胆囊病理之间的潜在关系.
主要方法:
- 对137个腹腔镜切除的胆囊进行分析.
- 组织学检查和PCR用于检测H. pylori.
- 在患有急性结石胆囊炎,慢性结石胆囊炎和胆囊多的患者中,对CXCL2和CXCL5基因表达分析进行定量实时PCR.
主要成果:
- 在胆囊组织的30.7% (史学) 和42.3% (PCR) 中检测到了H. pylori.
- 分别在62%和57.7%的病例中观察到CXCL2和CXCL5的表达升高,特别是在急性胆囊炎中更高.
- 在H. pylori存在和胆囊炎类型或化学激素表达之间没有发现统计学上显著的关联.
结论:
- 这项研究没有确定H. pylori感染和胆囊病理之间的直接因果关系.
- 胆囊疾病中CXCL2和CXCL5的上调可能受H.pylori以外的其他因素的影响.
- 需要进一步的研究来澄清H. pylori,化学因子和胆囊疾病病原体之间的复杂相互作用.
更多相关视频
相关概念视频
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
558
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
558
01:17Gastritis-II: Pathophysiology
296
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
296
01:30Peptic Ulcer Disease I: Introduction
162
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
162
01:28Peptic Ulcer Disease II: Pathophysiology
344
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
344
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
362
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
362
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
102
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
102